Carriers for DPIs: formulation and regulatory challenges

J. S. Kaerger, R. Price, P. M. Young, S. Edge, M. J. Tobyn

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Lactose, in particular alpha-lactose monohydrate, is typically used as 'the' carrier in dry powder inhalers. Even though these often tailored materials allow the delivery of medicines to the body in doses that are much lower than by 'conventional' solid dosage forms, the use of this excipient in this application is posing characterization and regulatory challenges to both suppliers and users.
Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalPharmaceutical Technology Europe
Issue number10
Publication statusPublished - 1 Oct 2006
Externally publishedYes


  • Dry Powder Inhalers
  • Spray Drying
  • Inhalation


Dive into the research topics of 'Carriers for DPIs: formulation and regulatory challenges'. Together they form a unique fingerprint.

Cite this